Skip to main content

Transgenomic Reports Decreased Q2 Revenues

NEW YORK, Aug. 5 (GenomeWeb News) - Transgenomic today reported decreased second-quarter revenues amid widened net losses.


The Omaha, Neb. company had revenues of $8.5 million for the quarter, compared to $9.4 million for the same period last year.


Losses totalled $4.7 million, compared to $4.0 million for the year-ago quarter.


R&D expenses decreased also, to $2.4 million, from $3.0 million in the same period last year.


As of June 30, the company had cash, cash equivalents, and short-term investments of $3.0 million.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.